(Q40964742)

reason for preferred rank

25 September 2017

title

Sequential chemoimmunotherapy of colorectal cancer. Evaluation of methotrexate, Baker's antifol and levamisole (English)

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Sequential chemoimmunotherapy of colorectal cancer: evaluation of methotrexate, Baker's Antifol and levamisole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

1 reference

1 reference

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

author name string

A. Y. Bedikian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

M. Valdivieso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

G. M. Mavligit

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

M. A. Burgess

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

V. Rodriguez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

G. P. Bodey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

language of work or name

English

0 references

publication date

1 November 1978

1 reference

full work available at URL

25 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

1 reference

25 September 2017

volume

42

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

2169-2176

1 reference

A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary report

25 September 2017

cites work

1

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

5-fluorouracil given once weekly: Comparison of intravenous and oral administration

8 April 2023

2

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study

8 April 2023

3

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

4

29

2308

Bruce

1969

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

1,3-Bis(2-Chloroethyl)-1-Nitrosourea (Bcnu) And Other Nitrosoureas In Cancer Treatment: A Review

8 April 2023

5

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Cancer Treatment Reports

7

60

769

Douglas

1976

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Fluorouracil, methyl-CCNU and vincristine in cancer of the colon

8 April 2023

8

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

8 April 2023

9

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Nonparametric Estimation from Incomplete Observations

8 April 2023

12

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Cancer Treatment Reports

15

60

1557

MacDonald

1976

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma

8 April 2023

16

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Brief Communication: Therapy of Advanced Colorectal Cancer With a Combination of 5-Flourouracil, Methyl-l,3-cis(2-chlorethyl)-1-nitrosourea, and Vincristine2

8 April 2023

18

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

19

32

1280

Moertel

1972

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Cancer Treatment Reports

20

60

729

Moertel

1976

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

21

37

980

Rodriguez

1977

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Levamisole in advanced human breast cancer

8 April 2023

22

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

23

29

2384

Schabel

1969

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma

8 April 2023

24

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma

8 April 2023

25

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Identifiers

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

1 reference

25 September 2017

1 reference